在第一线治疗前对Helicobacter pylori抗生素敏感性的系统评估:一组研究
Bernard Denis1, Laurianne Plastaras1, Izabella Amaritei1
1Department of Gastroenterology, Pasteur Hospital, Colmar, France.
United European gastroenterology journal
|August 21, 2025
概括
实行基于PCR的抗生素敏感性测试可指导有效的三重治疗,改善根除率并降低与实证治疗相比的成本.
科学领域:
- 胃肠病学
- 传染性疾病
- 临床微生物学
背景情况:
- 欧洲指南建议在开始治疗Helicobacter pylori之前进行抗生素敏感性测试.
- 经验治疗仍然是法国的标准,受敏感性引导的治疗并不常见.
研究的目的:
- 在一线治疗前评估系统抗生素敏感性测试的实施和结果.
- 评估PCR,组织学和培养对H. pylori检测和耐药性概况的诊断性能.
主要方法:
- 通过组织学,PCR和培养进行活检分析的食道胃管内镜的前性研究.
- 在开始第一线H. pylori治疗之前进行了系统的抗生素敏感性测试.
主要成果:
- 对于H. pylori的诊断,PCR显示出高灵敏度 (99.7%).
- 观察到高比例的克拉里素 (22. 6%) 和叶黄素 (18. 6%) 的耐药性.
- 与经验四重 bismuth 疗法 (81. 3%) 相比,受敏感性引导的三重疗法实现了显著更高的根除率 (98. 1% - 100%).
- 基于PCR的方法比基于免疫组织化学的方法更具成本效益.
结论:
- 在临床环境中,基于PCR的灵敏性导向策略很容易实现.
- 这种方法使得有效的三重疗法在效率和成本上胜过实证的四重 bismuth 疗法.
- 在一小部分患者中,培养试验为灵敏性导向治疗提供了增量效益.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
01:26Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145
00:57Antibiotic Selection
55.2K
Overview
55.2K
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
525
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
525
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
569
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
569